How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Intrauterine Insemination Device Market
- By Product Type: Disposable IUI Catheters, Reusable IUI Catheters, Sperm Collection Devices, Sperm Preparation Media, Syringes and Needles
- By Material: Silicone, Polyurethane, Latex-Free Materials, Polyethylene
- By End User: Fertility Clinics, Hospitals, Specialized Reproductive Health Centers, Home Care Settings
- By Application: Male Infertility Treatment, Female Infertility Treatment, Unexplained Infertility, Donor Insemination
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Disposable IUI Catheters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 274 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Intrauterine Insemination Device Market report
A complete, evidence-based study - 11 chapters and 115 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 4
End User 4
Application 4
Companies profiled
CooperSurgical Inc.
Cook Medical (a division of Cook Group)
Medi-Tech International Ltd.
Irvine Scientific Sales Company Inc.
Ferring Pharmaceuticals
Merck KGaA (MilliporeSigma)
Sage Therapeutics Inc.
Ningbo David Medical Device Co. Ltd.
Laborie Medical Technologies
Lifecodexx AG
Vitrolife AB
Origio (a CooperSurgical company)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →CooperSurgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cook Medical (a division of Cook Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Medi-Tech International Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Irvine Scientific Sales Company Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Ferring Pharmaceuticals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sage Therapeutics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Laborie Medical Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Lifecodexx AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Vitrolife AB
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Origio (a CooperSurgical company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Genea Biomedx Pty Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Cook Biotech Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Gynemed GmbH & Co. KG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,696M by 2033 · 7.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Disposable IUI Catheters47.8
- Reusable IUI Catheters15.5
- Sperm Collection Devices16.0
- Sperm Preparation Media13.2
- Syringes and Needles7.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,794M → $2,893M · 6.2%
Europe$1,250M → $2,302M · 7.9%
Asia Pacific$1,142M → $2,003M · 7.3%
Latin America$706.7M → $1,354M · 8.5%
Middle East and Africa$543.6M → $1,089M · 9.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.452026
7.472027
7.482028
7.482029
7.512030
7.522031
7.532032
7.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- CooperSurgical Inc.17.4
- Cook Medical (a division of Cook Group)21.5
- Medi-Tech International Ltd.10.4
- Irvine Scientific Sales Company Inc.5.6
- Ferring Pharmaceuticals7.3
- Merck KGaA (MilliporeSigma)9.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type34.4%
Material22.2%
End User12.6%
Application30.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.0
- Europe23.9
- Asia Pacific20.8
- Latin America14.0
- Middle East and Africa11.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| CooperSurgical Inc. | 99 | 81 | 95 | 86 | 94 | 98 | 92 |
| Cook Medical (a division of Cook Group) | 89 | 70 | 83 | 75 | 74 | 87 | 80 |
| Medi-Tech International Ltd. | 77 | 65 | 72 | 64 | 86 | 85 | 75 |
| Irvine Scientific Sales Company Inc. | 76 | 79 | 76 | 61 | 75 | 74 | 74 |
| Ferring Pharmaceuticals | 63 | 51 | 59 | 73 | 54 | 52 | 59 |
| Merck KGaA (MilliporeSigma) | 58 | 71 | 48 | 66 | 54 | 61 | 60 |
| Sage Therapeutics Inc. | 47 | 55 | 47 | 59 | 41 | 65 | 52 |
| Ningbo David Medical Device Co. Ltd. | 44 | 58 | 45 | 48 | 40 | 50 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- CooperSurgical Inc.
- Cook Medical (a division of Cook Group)
- Medi-Tech International Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| CooperSurgical Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cook Medical (a division of Cook Group) | ✓ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Medi-Tech International Ltd. | ✓ | ◐ | ◐ | − | ◐ | ◐ |
| Irvine Scientific Sales Company Inc. | ✓ | ◐ | ◐ | − | ◐ | ✓ |
| Ferring Pharmaceuticals | − | ◐ | − | ◐ | ◐ | ◐ |
| Merck KGaA (MilliporeSigma) | − | ◐ | ◐ | ◐ | − | − |
| Sage Therapeutics Inc. | − | ◐ | ◐ | − | − | ◐ |
| Ningbo David Medical Device Co. Ltd. | − | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1CooperSurgical Inc.92
2Cook Medical (a division of Cook Group)80
3Medi-Tech International Ltd.75
4Irvine Scientific Sales Company Inc.74
5Merck KGaA (MilliporeSigma)60
6Ferring Pharmaceuticals59
7Sage Therapeutics Inc.52
8Ningbo David Medical Device Co. Ltd.48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
CooperSurgical Inc.Cook Medical (a division of Cook Group)
Challenger2
Strong scale, closing on the leaders.
Medi-Tech International Ltd.Irvine Scientific Sales Company Inc.
Contender2
Focused players with pockets of strength.
Ferring PharmaceuticalsMerck KGaA (MilliporeSigma)
Niche2
Specialists in a single segment or region.
Sage Therapeutics Inc.Ningbo David Medical Device Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Intrauterine Insemination Device Market — a $227M beachhead inside a $3.61B market.
Beachhead (SOM)$227Mobtainable near-term
Serviceable (SAM)$1.24Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Disposable IUI Catheters
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Reusable IUI Catheters
Strong fit — clear ROI and a fast path to value.
End user68 fit
Sperm Collection Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel30%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Intrauterine Insemination Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified25%
Evaluation14%
Closed-won6%
$12.5KCAC
$49KLTV
3.9:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Intrauterine Insemination Device Market is a durable-growth opportunity — $2.29B by 2033, compounding at 7.1%.
TAM · 2025$1.32Btoday
TAM · 2033$2.29Bforecast
CAGR7.1%2027–2033
Cumulative$15.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.29BTotal addressable market
SAM$802MServiceable available market
SOM$148MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.29BLarge & growingTAM by 2033 at 7.1% CAGR
$802MServiceable nowreachable with today’s model
$148MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.78BBear4.6% CAGR
$2.29BBase7.1% CAGR
$2.93BBull9.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Intrauterine Insemination Device Market — a $2.81B market by 2033. Plan: grow share from 9.9% to 15.2%.
Market size · 2033$2.81Btotal addressable
Market CAGR8.8%2027–2033
Target share15.2%from 9.9% today
Revenue ambition$428Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.9% | 15.2% | On track |
| Revenue | $261M | $428M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 35.2% | 38.7% | Behind |
| Customer retention | 84.3% | 94.7% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $45M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Intrauterine Insemination Device Market conversation — a $4.98B market you can size, segment and defend in minutes.
Market size · 2033$4.98Btotal opportunity
Growth9.2%CAGR to 2033
Addressable buyers1,423+accounts in scope
Typical ROI6.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.6×return on cost, year one
< 4 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
CooperSurgical Inc.Cook Medical (a division of Cook Group)Medi-Tech International Ltd.Irvine Scientific Sales Company Inc.Ferring PharmaceuticalsMerck KGaA (MilliporeSigma)Sage Therapeutics Inc.Ningbo David Medical Device Co. Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Intrauterine Insemination Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Intrauterine Insemination Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Intrauterine Insemination Catheter Market
Market size, share, segmentation and regional forecast.
$605M market · 2025 base year
View reportIntrauterine Device with Copper Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportIntratumoral Cancer Therapies Market
Market size, share, segmentation and regional forecast.
$332M market · 2025 base year
View reportIntrathoracic Fixation System Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportIntrathecal Therapy Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportIntrathecal Pain Pump Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportIntrathecal Drug Pump Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportIntrathecal Drug Infusion System Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportIntrathecal Drug Delivery Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportIntrathecal Baclofen Therapy System Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportIntrasaccular Embolization System Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportIntrasaccular Device Market
Market size, share, segmentation and regional forecast.
$796M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.